Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Probable ATP-dependent RNA helicase DDX17 is a multifunctional RNA helicase belonging to the DEAD-box protein family, characterized by the conserved Asp-Glu-Ala-Asp motif. DDX17 regulates a variety of key cellular processes, including RNA secondary structure modification, pre-mRNA alternative splicing, ribosome and spliceosome assembly, microRNA processing, and acts as a transcriptional coactivator or corepressor, participating in chromatin remodeling and influencing chromatin accessibility. Its roles extend to cell differentiation, embryogenesis, and spermatogenesis. DDX17 is also implicated in disease processes such as cancer, where it may act as an oncogene or tumor suppressor, and in cardiovascular disease, where its expression correlates with protection against heart failure via support of mitochondrial homeostasis. DDX17 closely interacts with other helicases such as DDX5 and with chromatin modifiers (e.g., HDAC1, CBP/p300). The broad involvement and essential functions of DDX17 categorize it as a fundamental gene and protein for RNA metabolism and gene regulation, but currently, no therapeutics directly targeting DDX17 are in clinical use.
Not established for drugs, but as a target, modulation of ATP-dependent RNA unwinding, alteration of spliceosome function, or regulation of chromatin state are conceivable therapeutic mechanisms
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Probable ATP-dependent RNA helicase DDX17 (DDX17).